HDM2005 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1: 2Phase 1/2: 1

Top Sponsors

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.3

Indications

Cancer3
Advanced Solid Tumors2
Diffuse Large B-cell Lymphoma(DLBCL)1
Relapsed Hematologic Malignancy1
Refractory Lymphoma1

Other3 trials

A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma

Phase 1/2

A Study of HDM2005 in Patients With Advanced Solid Tumor

Phase 1

A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.